Drew E. Lewis
Drew E. Lewis publishes mostly in Pharmacology, Epidemiology and Molecular Medicine, on topics such as Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria and Antibiotic Use and Resistance.
- World rank
- #4,166,912 of 7,710,434 ranked researchers
- Rank in United States
- #1,127,061 of 1,627,098
- Works
- 16
- Citations
- 525
- Citations per work
- 32.8
What does Drew E. Lewis research?
Drew E. Lewis's work is mostly in Medicine (32%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else743.2%
- Health Sciences531.8%
- Medicine531.8%
- Life Sciences320.5%
- Physical Sciences14.5%
- Engineering14.5%
- 1Pharmacology16% of their works
- 2Epidemiology11% of their works
- 3Molecular Medicine11% of their works
- 4Applied Microbiology and Biotechnology9% of their works
- 5Emergency Medicine4% of their works
- 6Electrical and Electronic Engineering4% of their works
Research topics
Which keywords describe Drew E. Lewis's research?
The keywords of their largest research topics: Antibiotic Resistance, Antimicrobial Resistance, Epidemiology, Antibiotic Pharmacokinetics, Critically Ill Patients, ESKAPE Pathogens, Multidrug-Resistant Bacteria and Antimicrobial Stewardship.
- Poultry Coccidiosis
- Glycans
- Respiratory Syncytial Virus
- Human Metapneumovirus
- Community-Acquired Pneumonia
- Vaccine Development
- Antimicrobial Stewardship
- ESKAPE Pathogens
- Antibiotic Pharmacokinetics
- Antimicrobial Resistance
- Antibiotic Resistance
- Epidemiology
- Critically Ill Patients
- Multidrug-Resistant Bacteria
- Global Health
- Cassava
- Cyanogenic Glycosides
- Pneumococcal Conjugate Vaccine
- Anticoccidial Drugs
- Glycosylation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antibiotic Resistance92 topics
- Antimicrobial Resistance82 topics
- Epidemiology83 topics
- Antibiotic Pharmacokinetics61 topic
- Critically Ill Patients61 topic
- ESKAPE Pathogens51 topic
- Multidrug-Resistant Bacteria51 topic
- Antimicrobial Stewardship41 topic
- Global Health41 topic
- Vaccine Development32 topics
- Cassava21 topic
- Community-Acquired Pneumonia21 topic
- Cyanogenic Glycosides21 topic
- Human Metapneumovirus21 topic
- Pneumococcal Conjugate Vaccine21 topic
- Respiratory Syncytial Virus21 topic
- Anticoccidial Drugs11 topic
- Glycans11 topic
- Glycosylation11 topic
- Poultry Coccidiosis11 topic
Where does Drew E. Lewis work?
Drew E. Lewis's main affiliation in the publication record is Entasis Therapeutics (United States), United States.
How many publications and citations does Drew E. Lewis have?
OpenAlex counts 16 works and 525 citations for Drew E. Lewis, an h-index of 6, ranking #4,166,912 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Drew E. Lewis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.